Global private equity and venture capital news and research

Posts Tagged ‘Third Rock Ventures’

2 October 2015

Third Rock Ventures leads $55m Series A round in Neon Therapeutics

health Third Rock Ventures has lead a $55m Series A financing round in immuno-oncology startup Neon Therapeutics.

13 August 2015

VC-backed Global Blood Therapeutics raises $120m IPO

take-a-blood-sample-1428179-m Venture capital-backed Global Blood Therapeutics has raised $120m for its IPO after pricing its 6 million shares at $20 per share.

14 November 2014

Anti-cancer business Blueprint Medicines bags $50m VC-backed Series C

blueprint_real_estate_170sq A string of venture capital firms have backed a $50m Series C financing round for cancer treatment developer Blueprint Medicines.

29 August 2014

Venture capital-backed Rhythm files for Nasdaq IPO

nasdaq Venture capital-backed metabolic drug developer Rhythm has filed for an IPO on the Nasdaq exchange.

1 July 2014

Venture firms back $34m Series D for anti-heart failure device maker DC Devices

heart monitor medical healthcare A trio of venture capital firms have taken part in a $34m Series D funding round for DC Devices, which makes equipment designed to help treat heart failure.

22 May 2014

Nurix raises $25.1m Series B from Third Rock, The Column Group

biotech_lrg Third Rock Ventures and The Column Group have invested $25.1m in Series B capital in biotec startup Nurix, which is focused on developing therapies that modulate the ubiquitin proteasome system.

23 April 2014

Kala Pharmaceuticals scores $22.5m Series B

dollar envelope money Ysios Capital has led a $22.5m Series B round for Kala Pharmaceuticals, which is focused on developing ophthalmic products based on its mucus penetrating particle technology.

16 April 2014

Biopharma developer PanOptica scores $45m Series B investment

Biopharmaceutical company PanOptica has raised up to $45m in a Series B financing, co-led by new participant Novo Ventures and existing investor Third Rock Ventures, alongside founding investor SV Life Sciences.

20 March 2014

Third Rock, Prospect Ventures return for $34m NinePoint Medical Series B

surgey-operation-medical-healthcare-doctor-patient-hospital NinePoint Medical founding investors Third Rock Ventures and Prospect Venture Partners have renewed their commitment to the company by backing a $34m financing round.

13 March 2014

OrbiMed helps Sage Therapeutics raise $38m

medical monitor Healthcare-focused investment firm OrbiMed Advisors participated in a $38m Series C round for biopharmaceutical company Sage Therapeutics.

Page 1 of 3123

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015